{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:16:45Z","timestamp":1745986605883},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,3]]},"DOI":"10.7759\/cureus.63738","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T12:32:11Z","timestamp":1720009931000},"source":"Crossref","is-referenced-by-count":1,"title":["An Unusual Presentation of Multiple Sclerotic Bone Lesions in Unicentric Castleman\u2019s Disease"],"prefix":"10.7759","author":[{"given":"Santhosh","family":"Balapanga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annapureddy","family":"Kalyan Kumar Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushmitha","family":"D J","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muni Sai Varshith","family":"Thirupathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2017.09.001","article-title":"Epidemiology of Castleman Disease","volume":"32","author":"Simpson D","year":"2018","unstructured":"Simpson D. Epidemiology of Castleman Disease. Hematol Oncol Clin North Am. 2018, 32:1-10. 10.1016\/j.hoc.2017.09.001","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman disease","volume":"135","author":"Dispenzieri A","year":"2020","unstructured":"Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood. 2020, 135:1353-64. 10.1182\/blood.2019000931","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.21036","article-title":"Historical and pathological overview of Castleman disease","volume":"62","author":"Nishimura MF","year":"2022","unstructured":"Nishimura MF, Nishimura Y, Nishikori A, Yoshino T, Sato Y. Historical and pathological overview of Castleman disease. J Clin Exp Hematop. 2022, 62:60-72. 10.3960\/jslrt.21036","journal-title":"J Clin Exp Hematop"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00317-7","article-title":"Castleman disease","volume":"7","author":"Carbone A","year":"2021","unstructured":"Carbone A, Borok M, Damania B, et al.. Castleman disease. Nat Rev Dis Primers. 2021, 7:84. 10.1038\/s41572-021-00317-7","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2017.09.002","article-title":"Castleman Disease pathogenesis","volume":"32","author":"Fajgenbaum DC","year":"2018","unstructured":"Fajgenbaum DC, Shilling D. Castleman Disease pathogenesis. Hematol Oncol Clin North Am. 2018, 32:11-21. 10.1016\/j.hoc.2017.09.002","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref6","article-title":"Castleman Disease","author":"Ehsan N","year":"2024","unstructured":"Ehsan N, Zahra F. Castleman Disease. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003334","article-title":"International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease","volume":"4","author":"van Rhee F","year":"2020","unstructured":"van Rhee F, Oksenhendler E, Srkalovic G, et al.. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv. 2020, 4:6039-50. 10.1182\/bloodadvances.2020003334","journal-title":"Blood Adv"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1057683","article-title":"Unicentric form of Castleman\u00b4s disease, pitfalls of diagnosis and surgical treatment","volume":"13","author":"Molacek J","year":"2023","unstructured":"Molacek J, Treska V, Skalicky T, et al.. Unicentric form of Castleman\u00b4s disease, pitfalls of diagnosis and surgical treatment. Front Oncol. 2023, 13:1057683. 10.3389\/fonc.2023.1057683","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac481","article-title":"Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: Practical guidance for diagnosis","volume":"62","author":"Gonz\u00e1lez Garc\u00eda A","year":"2023","unstructured":"Gonz\u00e1lez Garc\u00eda A, Fern\u00e1ndez-Mart\u00edn J, Robles Marhuenda \u00c1. Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: Practical guidance for diagnosis. Rheumatology. 2023, 62:1426-35. 10.1093\/rheumatology\/keac481","journal-title":"Rheumatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25495","article-title":"POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management","volume":"94","author":"Dispenzieri A","year":"2019","unstructured":"Dispenzieri A. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management. Am J Hematol. 2019, 94:812-27. 10.1002\/ajh.25495","journal-title":"Am J Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200211002-00002","article-title":"Mechanism of action of rituximab","volume":"13","author":"Cerny T","year":"2002","unstructured":"Cerny T, Borisch B, Introna M, Johnson P, Rose AL. Mechanism of action of rituximab. Anticancer Drugs. 2002, 13:S3-10. 10.1097\/00001813-200211002-00002","journal-title":"Anticancer Drugs"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-862334","article-title":"International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease","volume":"132","author":"van Rhee F","year":"2018","unstructured":"van Rhee F, Voorhees P, Dispenzieri A, et al.. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018, 132:2115-24. 10.1182\/blood-2018-07-862334","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/2040620716653745","article-title":"Review of siltuximab in the treatment of multicentric Castleman's disease","volume":"7","author":"Sarosiek S","year":"2016","unstructured":"Sarosiek S, Shah R, Munshi NC. Review of siltuximab in the treatment of multicentric Castleman's disease. Ther Adv Hematol. 2016, 7:360-6. 10.1177\/2040620716653745","journal-title":"Ther Adv Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/263468-an-unusual-presentation-of-multiple-sclerotic-bone-lesions-in-unicentric-castlemans-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T12:32:15Z","timestamp":1720009935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/263468-an-unusual-presentation-of-multiple-sclerotic-bone-lesions-in-unicentric-castlemans-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.63738","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,3]]}}}